The enantiomers of SK&F 83566, a new selective D-1 dopamine antagonist, stereospecifically block stereotyped behaviour induced by apomorphine and by the selective D-2 agonist RU 24213-Reference-Cited by-同舟云学术

The enantiomers of SK&F 83566, a new selective D-1 dopamine antagonist, stereospecifically block stereotyped behaviour induced by apomorphine and by the selective D-2 agonist RU 24213

Published:1985-10 Issue:1-2 Volume:116 Page:183-186
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Molloy Anthony G.,Waddington John L.

Publisher

Elsevier BV

Subject

Pharmacology

Reference10 articles.

1. Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics;Christensen;Life Sci.,1984

2. Activity of two new potent dopaminergic agonists at the striatal and anterior pituitary levels;Euvrard;Neuropharmacology,1980

3. SCH 23390: the first selective dopamine D-1 antagonist;Hyttel;European J. Pharmacol.,1983

4. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems;Iorio;J. Pharmacol. Exp. Ther.,1983

5. Dopaminergic behaviour stereospecifically promoted by the D-1 agonist R-SK&F 38393 and selectively blocked by the D-1 antagonist SCH 23390;Molloy;Psychopharmacology,1984

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abnormal Activities in Cortico-Basal Ganglia Circuits in Movement Disorders;Handbook of Behavioral Neuroscience;2016

2. Synchronous Activity in Basal Ganglia Circuits;Handbook of Behavioral Neuroscience;2010

3. Impaired Thyroid Function Provoked by Neonatal Treatment with Drugs Affecting the Maturation of Monoaminergic and Opioidergic Neurons*);Experimental and Clinical Endocrinology & Diabetes;2009-07-16

4. Basal Ganglia Network Synchronization in Animal Models of Parkinson’s Disease;Cortico-Subcortical Dynamics in Parkinson¿s Disease;2008-12-31

5. Rapidly induced dopaminergic supersensitivity: D1/D2 receptor participation and its prevention by an MAO-inhibitor;Pharmacology Biochemistry and Behavior;2006-11